Parikshit Somani banned four years for doping: ‘Food contamination’ defense collapses

London — There is a paradox in sport: doping cases that create little public noise often reveal the most. The International Tennis Integrity Agency, known as ITIA, has confirmed that Indian tennis player Parikshit Somani, 26, has been banned for four years. He tested positive for trimetazidine at a lower-tier event in Astana, Kazakhstan, last year. Somani’s career-high ranking in doubles was No. 256. That number may not mean much to casual fans, but for a player trying to rise through the lower ranks of professional tennis, it represented a long journey. Trimetazidine is not an unfamiliar substance in sport. It is a heart medication used to treat angina and support energy metabolism in cardiac tissue. For athletes, however, it can improve endurance during intense exercise. That is why the World Anti-Doping Agency, WADA, bans it. Two of the most famous cases linked to this substance are Kamila Valieva and Sun Yang. Valieva, the Russian figure skater, caused a storm at the Beijing 2026 Olympics. Sun Yang, the Chinese swimmer, tested positive back in 2026. Somani now enters the same page of history, but without the flashbulbs or live television coverage. What makes this case notable is not the player’s fame, but his explanation. Before the independent tribunal, Somani said the positive result came from food contaminated with medication used by a family member. In his telling, the medicine accidentally got into his meal. He did not deliberately use a banned substance; he was the victim of an accident at home. The story may sound plausible, but the judges called it “scientifically implausible,” “highly speculative,” and “unconvincing.” This explanation closely resembles the defense once presented in the Valieva case. Valieva’s lawyers argued that the banned substance entered her body through a glass of water contaminated with her grandfather’s medication. The international tribunal rejected that argument. Valieva was still banned for four years. Somani received the same outcome. The fact that both cases involved the same substance, the same type of excuse, and the same length of ban is not a coincidence. It reflects how tribunals weigh evidence: they need science, not scripts. At the hearing in August, Somani’s side did not prove the source of the alleged contamination. They did not identify which relative was involved, did not provide a prescription, did not describe the specific meal, did not establish a timeline, and did not explain why the concentration in his sample was so high. When a defense theory is placed on the scale, it must withstand challenging questions. Somani’s theory collapsed early. Modern anti-doping law is built on strict liability. Athletes are responsible for any banned substance found in their body, whether they intended to use it or not. To escape a ban, they must prove that they are “not at fault” or “not significantly at fault.” The standard is intentionally high, because the system understands that if a simple claim of contamination were enough, every athlete would use it. That is why Somani’s story was insufficient. In football, people sometimes say: “There is a fire in the locker room,” referring to team spirit. In tennis, locker rooms are quieter. Players sit alone, wrap their own bandages, take calls from their coaches, and face defeat by themselves. Somani probably lived through those days during his long path through smaller tournaments. He traveled on cheap flights, carried his own bags, and found practice courts on his own. Professional tennis is not only Wimbledon; much of the sport happens at venues where the stands are nearly empty. It was at such an event that his career changed direction. I watch, I record, I keep. Observing from the sidelines for years, I have noticed that lower-ranked athletes often lack legal knowledge. They do not know what powers WADA has, how ITIA operates, how to appeal, and most importantly, they do not know how to protect themselves in an environment that is not always clean. Somani may have been deliberate, or he may have been careless. Either way, he must pay. The line between “accidental” and “at fault” is so thin that one poorly controlled meal can end a career. The ban does not only stop him from competing. ITIA stated that Somani cannot play, cannot coach, and cannot attend any event organized by the world tennis system, the WTA, the ATP, the Grand Slams, or national federations. In other words, he has been removed from the entire organized tennis community. He cannot enter the court area, cannot sit in the coach’s chair, cannot stand in the stands and cheer. For someone who has lived with tennis since childhood, this punishment is like exile. Some may ask: Why is a player ranked No. 256 treated as strictly as a star? Is the system picking on small athletes? I believe the opposite is true. If the system let Somani go, it would create a loophole for richer players with better lawyers to exploit. A fair anti-doping system is one that applies the same standard to everyone. Grand Slam champion or No. 256 in doubles, responsibility for a banned substance is the same. The only difference is the level of media attention. But there is another question: Are lower-ranked athletes properly protected? They do not have personal nutritionists, full-time sports lawyers, or private doctors. They depend on coaches, but coaches may not fully understand the prohibited list. They receive small scholarships or pay from their own pockets. ITIA offers online education programs, but it is not easy for a player at a small tournament to read and understand everything. The gap between rules and reality remains. The Somani ban suggests that the gap is narrowing, but it has not disappeared. Consider trimetazidine itself. It is not a common gym substance, not a muscle-building steroid, not a stimulant like amphetamine. Trimetazidine is a heart medication. It is rare for an athlete to accidentally consume contaminated supplements containing this substance. Therefore, when a sample comes back positive, tribunals often ask: Why does a healthy young athlete have heart medication in his body? The answer “contaminated food” is very difficult to accept without a full chain of evidence. Somani did not provide it. Valieva did not either. Sun Yang’s history is more complicated, but the banned substance was still there. For Indian tennis, this case is an unwelcome stain. India has produced notable players at different times, but success has come from individuals, not from a synchronized development system. Young Indian players face more obstacles than their peers in Europe or the Americas: they are far from tennis centers, travel costs are high, courts are scarce, and domestic tournaments are not competitive enough. When one of them is banned for doping, the story is no longer only about one person. It raises questions about how Indian players are educated about banned substances, food, and supplements. Do they know that “tonics” bought online can contain banned ingredients? Will they refuse food prepared by relatives before a tournament? From my own observations, I believe most athletes do not want to cheat. They train hard, lose sleep over worries, accept injuries for a chance to step onto the court. But the pressure to climb the rankings is enormous. A doubles player ranked 256 may think that a few more wins will bring him closer to a stable income. In that context, using a substance that supports endurance can become a temptation. Or the opposite: he may become a victim of ignorance. Anti-doping law does not distinguish those two scenarios without evidence. The only thing that matters is the strength of the defense. Somani’s defense was weak. The tribunal called his food-contamination theories “scientifically implausible,” “highly speculative,” and “unconvincing.” The language was strong enough to show that the judges did not waver. That sends a clear message to the tennis world: do not repeat the Valieva-style excuse and expect a different outcome. The ban runs until September 2029. Four years is long enough for a player to lose his ranking, his competitive rhythm, and his motivation. When Somani returns, he will be 30. In a sport that constantly gets younger, returning from a ban is almost impossible. He may have to switch to coaching, become a commentator, or walk away from the sport. The ball rolls past, and the person remains. But the person left behind with a ban no longer sees the court the same way. Looking at the bigger picture, the Somani case shows that the fight against doping is not only fought at the elite level. It reaches into small tournaments with few spectators, matches on outside courts, and hotel corridors where players manage their own meals. A urine sample in Astana became the center of attention. Without ITIA, no one would know the name Parikshit Somani. But because of an independent investigation, he has become part of a larger story: the fragile boundary between career and mistake. Before the match begins, listen. On a tennis court, we hear the bounce of the ball, the sound of shoes sliding, the breath of the player. The anti-doping system has another sound: the opening of a sample bottle, the typing of lawyers, the sound of a verdict. Those sounds do not appear on television, but they decide lives. One beat, one day, one season. For Somani, the next season has been stopped before the ball could be tossed. This ban is also a reminder for young tennis players: do not trust promises about “safe supplements,” do not let relatives add medicine to your food, do not think you are too small to be tested. ITIA does not need your reputation to open a file. They need your sample. A glass of water, a piece of meat, a cold tablet can be the reason you stand before a tribunal. Somani stood there. He could not convince them that he was innocent. And he paid the price. In the long run, tennis needs a stronger anti-doping education strategy, especially at lower-tier events and in countries with developing systems. Players need access to nutritional advice, the prohibited list, the appeal process, and a channel to report threats. Somani may not be the last player to face a trimetazidine problem. But if the system learns from this case, sport will lose one loophole. London was quiet after the announcement. There was no major press conference, no trending hashtag. But in the small offices of lower-ranked players, there must have been conversations about Somani’s lesson. They will ask themselves: Is my food safe? Does the supplement I take appear on the prohibited list? Is a relative unintentionally putting me at risk? Those questions are the real value of a case that offered no mercy. In tennis, they say the match is not over until the final point lands. The Somani case reminds us that a career is no different. A forehand, a serve, a return… all of it can become a memory if you lose the right to enter the court. Somani has lost that right. He can practice at a private club or play with friends, but there will be no referee, no score, no crowd watching. That is the life of someone placed outside the game. And when the ban ends, will he even want to return? Elite sport does not forgive four lost years. But even if every door closes, his case leaves a legacy: another proof that the “food contamination” excuse is not automatically accepted. Before anyone tries that excuse again, they should prepare real scientific evidence. A small doping case in Astana, an Indian doubles player ranked 256, a four-year ban. On the surface, it is not a big story. But for those who have followed tennis for a long time, it is an important signal: the anti-doping system is cleaning even the darkest corners. If he cannot escape the sanction, no one can. I keep watching. In the coming days, there may be a response from Somani or his lawyers. There may be an appeal to the Court of Arbitration for Sport, known as CAS. Either way, the story is not over. But for Somani’s playing career, the ruling feels like a full stop, at least until September 2029. A silence longer than any silence between two points.